Lupin Limited has informed the Exchange about press release dated 07-Sep-2022 titled Lupin and DKSH Sign an Exclusive Licensing and Supply Agreement to Market Five Biosimilar Candidates in the Philippines.
Lupin Limited has informed the Exchange about press release dated 07-Sep-2022 titled Lupin and DKSH Sign an Exclusive Licensing and Supply Agreement to Market Five Biosimilar Candidates in the Philippines.